Bliss GVS Pharma Ltd
Bliss GVS Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Bliss GVS Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Bliss GVS Pharma Ltd Share Price Chart
Bliss GVS Pharma Ltd Fundamentals
Traded Volume: 2,52,699
Market Cap(Cr): 1,689
Avg Traded Price 160.44
1 Year return 23.81%
Upper Circuit 163
Lower Circuit 158.5
P/E TTM 15.00
P/B Ratio 10.00
Traded Value(Cr) 403.79
EPS TTM 10.370
Book value 10.370
Dividend 0.00%
Bliss GVS Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Bliss GVS Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Bliss GVS Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -4.56%
1M +2.81%
3M -3.91%
1Y +23.81%
YTD -8.78%
Bliss GVS Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Bliss GVS Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 4.22L
Day Before Yesterday 3.90L
1W Avg 6.12L
1M Avg 22.45L
3M Avg 10.88L
Bliss GVS Pharma Ltd Technical Details
Bliss GVS Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 158
Support 2 156
Support 3 153
Pivot Point : 160
Resistance 1 162
Resistance 2 165
Resistance 3 167
Bliss GVS Pharma Ltd Corporate Actions
Bliss GVS Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Bliss GVS Pharma Ltd’s capital allocation strategies.
All
Ex-Date 24-Jul-2025 Type D Description 0.50/share@50.00% Record Date 24-Jul-2025 Ratio 50.00
Ex-Date 18-Jul-2024 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 12-Jul-2023 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 20-Jun-2022 Type D Description 0.50/share@50.00% Record Date 21-Jun-2022 Ratio 50.00
Ex-Date 13-Sep-2021 Type D Description 0.50/share@50.00% Record Date 14-Sep-2021 Ratio 50.00
Ex-Date 17-Sep-2020 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 12-Sep-2019 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 14-Aug-2018 Type D Description 1.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 18-Sep-2017 Type D Description 0.60/share@60.00% Record Date - Ratio 60.00
Ex-Date 06-Sep-2016 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 08-Sep-2015 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 24-Feb-2015 Type D Description 0.20/share@20.00% Record Date 25-Feb-2015 Ratio 20.00
Ex-Date 13-Aug-2014 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 01-Aug-2013 Type D Description 0.40/share@40.00% Record Date - Ratio 40.00
Ex-Date 25-Feb-2013 Type D Description 0.30/share@30.00% Record Date 26-Feb-2013 Ratio 30.00
Ex-Date 02-Aug-2012 Type D Description 0.40/share@40.00% Record Date - Ratio 40.00
Ex-Date 24-Nov-2011 Type D Description 0.35/share@35.00% Record Date 25-Nov-2011 Ratio 35.00
Ex-Date 14-Jul-2011 Type D Description 0.30/share@30.00% Record Date - Ratio 30.00
Ex-Date 25-Nov-2010 Type D Description 0.30/share@30.00% Record Date 27-Nov-2010 Ratio 30.00
Ex-Date 22-Jul-2010 Type D Description 0.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 13-Aug-2009 Type D Description 0.15/share@15.00% Record Date - Ratio 15.00
Ex-Date 26-Sep-2008 Type B Description share@3:5 Record Date 30-Sep-2008 Ratio 3:5
Ex-Date 14-May-2008 Type D Description 0.10/share@10.00% Record Date 15-May-2008 Ratio 10.00
Ex-Date 11-Mar-2008 Type S Description share@1:10.00 Record Date 18-Mar-2008 Ratio 1:10.00
Ex-Date 13-Sep-2007 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Dividends
Announcement Date 24-Jul-2025 Ex Dividend Date 24-Jul-2025 Dividend(%) 50
Announcement Date 18-Jul-2024 Ex Dividend Date 18-Jul-2024 Dividend(%) 50
Announcement Date 12-Jul-2023 Ex Dividend Date 12-Jul-2023 Dividend(%) 50
Announcement Date 20-Jun-2022 Ex Dividend Date 20-Jun-2022 Dividend(%) 50
Announcement Date 13-Sep-2021 Ex Dividend Date 13-Sep-2021 Dividend(%) 50
Announcement Date 17-Sep-2020 Ex Dividend Date 17-Sep-2020 Dividend(%) 50
Announcement Date 12-Sep-2019 Ex Dividend Date 12-Sep-2019 Dividend(%) 100
Announcement Date 14-Aug-2018 Ex Dividend Date 14-Aug-2018 Dividend(%) 100
Announcement Date 18-Sep-2017 Ex Dividend Date 18-Sep-2017 Dividend(%) 60
Announcement Date 06-Sep-2016 Ex Dividend Date 06-Sep-2016 Dividend(%) 50
Announcement Date 08-Sep-2015 Ex Dividend Date 08-Sep-2015 Dividend(%) 50
Announcement Date 24-Feb-2015 Ex Dividend Date 24-Feb-2015 Dividend(%) 20
Announcement Date 13-Aug-2014 Ex Dividend Date 13-Aug-2014 Dividend(%) 50
Announcement Date 01-Aug-2013 Ex Dividend Date 01-Aug-2013 Dividend(%) 40
Announcement Date 25-Feb-2013 Ex Dividend Date 25-Feb-2013 Dividend(%) 30
Announcement Date 02-Aug-2012 Ex Dividend Date 02-Aug-2012 Dividend(%) 40
Announcement Date 24-Nov-2011 Ex Dividend Date 24-Nov-2011 Dividend(%) 35
Announcement Date 14-Jul-2011 Ex Dividend Date 14-Jul-2011 Dividend(%) 30
Announcement Date 25-Nov-2010 Ex Dividend Date 25-Nov-2010 Dividend(%) 30
Announcement Date 22-Jul-2010 Ex Dividend Date 22-Jul-2010 Dividend(%) 50
Announcement Date 13-Aug-2009 Ex Dividend Date 13-Aug-2009 Dividend(%) 15
Announcement Date 14-May-2008 Ex Dividend Date 14-May-2008 Dividend(%) 10
Announcement Date 13-Sep-2007 Ex Dividend Date 13-Sep-2007 Dividend(%) 10
Bonus
Record Date 30-Sep-2008 Ex-Bonus Date 26-Sep-2008 Ratio 3:5
Splits
Record Date 18-Mar-2008 Split Date 11-Mar-2008 Face Value (Before/After) 10.00/1.00
Others
Rights No Rights has been declared by BLISSGVS
Bliss GVS Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Bliss GVS Pharma Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Bliss GVS Pharma Ltd's relative performance and valuation against major competitors.
Stock Name Novartis India Ltd ₹672.25 (-2.48%) M. Cap (Cr) 16.60 1 Yr Return (%) -1.49% P/E (TTM) 19.25 PB Ratio 2.81
Stock Name Amrutanjan Health Care Ltd ₹696.00 (-0.69%) M. Cap (Cr) 20.12 1 Yr Return (%) -1.35% P/E (TTM) 35.49 PB Ratio 6.16
Stock Name Shukra Pharmaceuticals Ltd ₹40.89 (-1.99%) M. Cap (Cr) 17.90 1 Yr Return (%) +601.37% P/E (TTM) 149.73 PB Ratio 32.98
Stock Name Bliss GVS Pharma Ltd ₹159.79 (-1.30%) M. Cap (Cr) 16.89 1 Yr Return (%) +23.81% P/E (TTM) 15.41 PB Ratio 1.67
Stock Name Beta Drugs Ltd ₹1661.10 (+1.72%) M. Cap (Cr) 16.77 1 Yr Return (%) -12.04% P/E (TTM) 39.53 PB Ratio 9.27
Stock Name Windlas Biotech Ltd ₹794.05 (-1.27%) M. Cap (Cr) 16.74 1 Yr Return (%) -14.31% P/E (TTM) 24.72 PB Ratio 3.53
Stock Name Syncom Formulations (India) Ltd ₹15.87 (-0.81%) M. Cap (Cr) 14.92 1 Yr Return (%) -19.73% P/E (TTM) 23.64 PB Ratio 4.36
Bliss GVS Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Bliss GVS Pharma Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 97.21 Mar 2024 125.92 Mar 2023 43.81 Mar 2022 114.05 Mar 2021 66.97
PARTICULARS Investing Activities Mar 2025 -77.73 Mar 2024 -109.59 Mar 2023 -12.97 Mar 2022 -92.28 Mar 2021 -61.62
PARTICULARS Financing Activities Mar 2025 -26.71 Mar 2024 -20.76 Mar 2023 -26.05 Mar 2022 -12.62 Mar 2021 -11.67
PARTICULARS Net Cash Flow Mar 2025 -7.23 Mar 2024 -4.43 Mar 2023 4.79 Mar 2022 9.14 Mar 2021 -6.33
Bliss GVS Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Bliss GVS Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 35.39%
Public 45.36%
Other Institutions 5.98%
FII 13.27%
Mutual Funds null%
About Bliss GVS Pharma Ltd
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its manufacturing facility at Palghar which is WHO GMP approved. The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards.The company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).During the year under review, the company invested in 51% share capital of Lifeon Labs Pvt Ltd. During the year under review, Bliss GVS Pharma faced challenges in Ghana, where delays in registration resulted in adverse regulatory action. However, the company took quick, corrective measures to resolve these issues. The business is now backing on track in Ghana.During the year ended 31 March 2015, Bliss GVS Pharma formed a new company Asterisk Lifesciences Limited as a wholly owned foreign subsidiary in United Kingdom for the purpose of facilitating registrations and marketing of pharmaceutical formulations in the European continent.During the financial year ended 31 March 2016, Bliss GVS Pharma continued to grow in various geographies in Kenya, Nigeria and France. Such growth was mainly achieved due to contract manufacturing and consistent focus on new product launch in Kenya and Nigeria. Bliss GVS Pharma continued to strengthen its operations and creation of robust Quality Manufacturing operations during the year ended 31 March 2017,The company's investment in managed healthcare services delivered encouraging results with the company procuring USD 111.40 mMillion contract from Aon. During the year ended 31 March 2018, Bliss GVS Pharma divested three subsidiaries viz. Lifeon Labs Private Limited, Bliss Indasi Lifescience Private Limited and Shree Salespack Private Limited and one materially significant step down subsidiary Bliss GVS Healthcare Limited, Nairobi to focus on its core pharmaceutical operations, which have been a steady source of growth.The Company set up a multi-dosage facility at Vevoor, Maharashtra in 2019. The first phase commissioned earlier in March, 2020, primarily for Tablets, Capsules, Dry Syrups, and Sachets. While the second phase commenced construction in January, 2021.The Company achieved USFDA approval for the manufacturing unit at Palghar in FY 2024. In FY 2025, it commissioned a state-of-the-art semi-solid plant at Vevoor. It singed strategic agreements with clients across the US, Canada and Europe, by adding presence in regulated market during the year 2025.
Whole-time Director
Vibha G Sharma
Registered office 102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072
FAX :91-22-42160000
Background
Incorporation Year 1984
Face Value ₹1.00
Market Lot 1
FAQs on Bliss GVS Pharma Ltd
How to buy Bliss GVS Pharma Ltd shares on NSE?
To buy Bliss GVS Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Bliss GVS Pharma Ltd share price today?
The Bliss GVS Pharma Ltd share price on NSE is ₹159.79 today.
What is the market cap of Bliss GVS Pharma Ltd on NSE?
The company has a market capitalization of ₹1689.34.
What is the PE & PB ratio of Bliss GVS Pharma Ltd?
PE is 15 and PB is 10.
What is the 52 Week High and Low of Bliss GVS Pharma Ltd shares?
Bliss GVS Pharma Ltd stock price high: ₹190.97 Bliss GVS Pharma Ltd stock price low: ₹108.12.